Indian Pharmacopoeia Commission proposes revisions to drug monographs

The Indian Pharmacopoeia Commission has proposed revisions to several drug monographs for inclusion in the Indian Pharmacopoeia, including additional requirements for bacterial endotoxins, sterility and related quality tests. The revisions are important as they seek to strengthen quality standards and testing requirements for pharmaceutical products covered under the pharmacopoeia.

Join our 1500+ subscribers to get our daily Health Laws and Policy Updates.